How Gilead’s Pharmaceutical Development and Manufacturing Team Delivers Transformative Medicines

(3:34)

Gilead Sciences CEO on raising full-year guidance due to remdesivir sales

(2:58)

Gilead Sciences CEO Daniel O'Day on the collaboration with biotech firm Galapagos

(4:48)

Our HIV Anthem: Helping End the HIV Epidemic

(5:1econd)

San Francisco Community Health Center x Gilead: Helping Increase Access to HIV Care

(3:34)

AWS re:Invent 2024 - Gilead Sciences: Operational excellence for cloud, data, and AI/ML (PRO302)

(1:1:17)

Gilead Sciences, Inc: A Commitment To Innovation

(5:31)

Gilead Sciences and EJAF Announce Further Five-Year RADIAN Partnership

(5:17)

Gilead slashing prices of top-selling hepatitis C drugs

(2:14)

Gilead Zero Hour Episode 1: Confronting Bias

(35:36)

Gilead graduates - 14 years of silence (part 2)

(48:21)

AWS re:Invent 2022 - Gilead Sciences’ journey from migration to innovation on AWS (LFS202)

(50:50)

Fireside Chat With John F. Milligan, PhD, President and Chief Operating Officer, Gilead Sciences

(26:37)

Inside the Innovation: Oncology Leaders Daejin Abidoye and Oriana Wiklund Discuss Life at Gilead

(5:16)

Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV

(5:25)

Gilead Sustainability \u0026 Innovation

(3:42)

Only Two Shots Yearly Enough for HIV Prevention

(12:29)

Gilead Helps Put African Nation on Path to Eliminate Hepatitis C

(3:36)

COMPASS Initiative 5 Years, 5 Voices: Transinclusive Group, South Florida

(3:41)

How Gilead Sciences Leverages Boomi | A @SolutionsReview with Murali Anakavur

(14:14)

Daniel O’Day of Gilead Sciences, Inc. on COVID-19 Efforts

(26)

30 Days, 30 Countries: Shaming Greedy Gilead Sciences

(1:17)

#Ad paid and presented by Gilead Sciences. How Gilead is helping to create a healthier Asia. #cancer

(37)

Gilead a leader in the HIV medication space: Health care researcher

(2:50)

Alan Walker, K-391 \u0026 Emelie Hollow - Lily (Lyrics)

(3:16)

I FINALLY MET THE BEST JOHNSON IN THE UNIVERSE! SUPER DEADLY COMBO!!!

(18:28)

Bloomberg Turnaround: AstraZeneca

(24:7)

AWS re:Invent 2024 - Gilead Sciences' AWS migration: From VMware to cloud transformation (MAM214)

(56:52)

Can Gilead Sciences Maintain Its Dominance in HIV Treatment?

(2:44)

Gilead Sciences to acquire Immunomedics in $21 billion deal

(7:10)

What's Gilead Sciences Doing With All That Cash?

(2:45)